India Generic Blood Pressure Drugs Recalled Again in U.S.

Source: Reuters

Jun 19, 2014

India's Dr Reddy's Laboratories is recalling 13,560 bottles of its high blood pressure drug, metoprolol succinate -- a generic form of AstraZeneca Plc's Toprol XL -- in the United States after the drug failed a dissolution test.

In May, Wockhardt also recalled 109,744 bottles of its generic version of AstraZeneca's Toprol XL in the U.S. for the same reason.

A failed dissolution test means a tablet did not disintegrate in the required period of time. Active absorption of oral dosage forms depends on adequate release of the API from the product, so dissolution plays a pivotal role in this. The Dr Reddy's recall, like the Wockhardt recall, was classified by the FDA as Class II -- meaning use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Read the Reuters press release

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments